Researchers examined the germline DNA of Hispanic women with BRCA-negative breast cancer to pinpoint pathogenic variants.
A new study found an upward trend over the last 12 years of cases of gastrointestinal cancer in young patients in Latin America.
A new study examined whether stereotactic body radiotherapy prior to pembrolizumab improved response rate in lung cancer patients.
A new analysis suggests more people may benefit from more inclusive lung cancer screening guidelines.
Novel research suggests that using a nano-molecularly imprinted polymer may offer a unique and effective way to treat HER2+ breast cancer.
Researchers tested the novel antibody-drug conjugate trastuzumab duocarmazine in patients with heavily pretreated HER2-expressing metastatic cancers, including breast cancer.
A new study used two patient-reported measures of sexual function following radical prostatectomy to assess sexual interest and satisfaction in men with prostate cancer.
Researchers compared several glucocorticoid regimens, given in combination with abiraterone acetate, for metastatic castration-resistant prostate cancer.
The FaMRIsc trial was designed to compare MRI and mammography screening in women with familial risk but no known specific driver mutation.
ASCO has updated its endorsement of a guideline regarding adjuvant systemic therapy decisions for early-stage operable breast cancer.